Literature DB >> 26063058

SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes.

Wenqi Cui1, Mengxi Sun1, Nadezhda Galeva1, Todd D Williams1, Yoshiaki Azuma1, Jeff L Staudinger2.   

Abstract

Several nuclear receptor (NR) superfamily members are known to be the molecular target of either the small ubiquitin-related modifier (SUMO) or ubiquitin-signaling pathways. However, little is currently known regarding how these two post-translational modifications interact to control NR biology. We show that SUMO and ubiquitin circuitry coordinately modifies the pregnane X receptor (PXR, NR1I2) to play a key role in regulating PXR protein stability, transactivation capacity, and transcriptional repression. The SUMOylation and ubiquitylation of PXR is increased in a ligand- and tumor necrosis factor alpha -: dependent manner in hepatocytes. The SUMO-E3 ligase enzymes protein inhibitor of activated signal transducer and activator of transcription-1 (STAT1) STAT-1 (PIAS1) and protein inhibitor of activated STAT Y (PIASy) drive high levels of PXR SUMOylation. Expression of protein inhibitor of activated stat 1 selectively increases SUMO(3)ylation as well as PXR-mediated induction of cytochrome P450, family 3, subfamily A and the xenobiotic response. The PIASy-mediated SUMO(1)ylation imparts a transcriptionally repressive function by ameliorating interaction of PXR with coactivator protein peroxisome proliferator-activated receptor gamma coactivator-1-alpha. The SUMO modification of PXR is effectively antagonized by the SUMO protease sentrin protease (SENP) 2, whereas SENP3 and SENP6 proteases are highly active in the removal of SUMO2/3 chains. The PIASy-mediated SUMO(1)ylation of PXR inhibits ubiquitin-mediated degradation of this important liver-enriched NR by the 26S proteasome. Our data reveal a working model that delineates the interactive role that these two post-translational modifications play in reconciling PXR-mediated gene activation of the xenobiotic response versus transcriptional repression of the proinflammatory response in hepatocytes. Taken together, our data reveal that the SUMOylation and ubiquitylation of the PXR interface in a fundamental manner directs its biologic function in the liver in response to xenobiotic or inflammatory stress.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26063058      PMCID: PMC4538856          DOI: 10.1124/dmd.115.065201

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  65 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

Review 2.  SUMO junction-what's your function? New insights through SUMO-interacting motifs.

Authors:  Oliver Kerscher
Journal:  EMBO Rep       Date:  2007-06       Impact factor: 8.807

3.  Small ubiquitin-related modifier (SUMO)-specific proteases: profiling the specificities and activities of human SENPs.

Authors:  Jowita Mikolajczyk; Marcin Drag; Miklós Békés; John T Cao; Ze'ev Ronai; Guy S Salvesen
Journal:  J Biol Chem       Date:  2007-06-25       Impact factor: 5.157

4.  Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression.

Authors:  Yatrik M Shah; Xiaochao Ma; Keiichirou Morimura; Insook Kim; Frank J Gonzalez
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-12-14       Impact factor: 4.052

5.  SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR.

Authors:  Benoit Pourcet; Inés Pineda-Torra; Bruno Derudas; Bart Staels; Corine Glineur
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

6.  Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha. Functional implications in hepatic cholesterol and glucose metabolism.

Authors:  Sonali Bhalla; Cengiz Ozalp; Sungsoon Fang; Lingjin Xiang; Jongsook Kim Kemper
Journal:  J Biol Chem       Date:  2004-08-18       Impact factor: 5.157

7.  A systematic analysis of predicted phosphorylation sites within the human pregnane X receptor protein.

Authors:  Kristin Lichti-Kaiser; Dan Brobst; Chenshu Xu; Jeff L Staudinger
Journal:  J Pharmacol Exp Ther       Date:  2009-07-17       Impact factor: 4.030

8.  Inflammatory mediators increase SUMOylation of retinoid X receptor α in a c-Jun N-terminal kinase-dependent manner in human hepatocellular carcinoma cells.

Authors:  Rebecca Schneider Aguirre; Saul J Karpen
Journal:  Mol Pharmacol       Date:  2013-05-20       Impact factor: 4.436

9.  Identification and characterization of phosphorylation sites within the pregnane X receptor protein.

Authors:  Ayesha Elias; Anthony A High; Ashutosh Mishra; Su Sien Ong; Jing Wu; Junmin Peng; Taosheng Chen
Journal:  Biochem Pharmacol       Date:  2013-10-30       Impact factor: 5.858

10.  SUMOylation of PPARγ by rosiglitazone prevents LPS-induced NCoR degradation mediating down regulation of chemokines expression in renal proximal tubular cells.

Authors:  Ying Lu; Qiao Zhou; Yongbing Shi; Jian Liu; Fang Zhong; Xu Hao; Cong Li; Nan Chen; Weiming Wang
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

View more
  9 in total

1.  Acetylation of lysine 109 modulates pregnane X receptor DNA binding and transcriptional activity.

Authors:  Danielle Pasquel; Aneta Doricakova; Hao Li; Sandhya Kortagere; Matthew D Krasowski; Arunima Biswas; William G Walton; Matthew R Redinbo; Zdenek Dvorak; Sridhar Mani
Journal:  Biochim Biophys Acta       Date:  2016-02-23

2.  A SUMO-acetyl switch in PXR biology.

Authors:  Wenqi Cui; Mengxi Sun; Shupei Zhang; Xunan Shen; Nadezhda Galeva; Todd D Williams; Jeff L Staudinger
Journal:  Biochim Biophys Acta       Date:  2016-02-12

3.  Phosphorylation Modulates the Coregulatory Protein Exchange of the Nuclear Receptor Pregnane X Receptor.

Authors:  Wenqi Cui; Xunan Shen; Emre Agbas; Brandon Tompkins; Hadley Cameron-Carter; Jeff L Staudinger
Journal:  J Pharmacol Exp Ther       Date:  2020-03-23       Impact factor: 4.030

Review 4.  Not So Slim Anymore-Evidence for the Role of SUMO in the Regulation of Lipid Metabolism.

Authors:  Amir Sapir
Journal:  Biomolecules       Date:  2020-08-06

Review 5.  Insights into the critical role of the PXR in preventing carcinogenesis and chemotherapeutic drug resistance.

Authors:  Xiaxia Niu; Ting Wu; Gege Li; Xinsheng Gu; Yanan Tian; Hongmei Cui
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 6.  Regulation of PXR Function by Coactivator and Corepressor Proteins: Ligand Binding Is Just the Beginning.

Authors:  Juan Pablo Rigalli; Dirk Theile; Julie Nilles; Johanna Weiss
Journal:  Cells       Date:  2021-11-12       Impact factor: 6.600

7.  Induction by Phenobarbital of Phase I and II Xenobiotic-Metabolizing Enzymes in Bovine Liver: An Overall Catalytic and Immunochemical Characterization.

Authors:  Michela Cantiello; Monica Carletti; Mery Giantin; Giulia Gardini; Francesca Capolongo; Paolo Cascio; Marianna Pauletto; Flavia Girolami; Mauro Dacasto; Carlo Nebbia
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

Review 8.  The Interface between Cell Signaling Pathways and Pregnane X Receptor.

Authors:  Robert S Rogers; Annemarie Parker; Phill D Vainer; Elijah Elliott; Dakota Sudbeck; Kaushal Parimi; Venkata P Peddada; Parker G Howe; Nick D'Ambrosio; Gregory Ruddy; Kaitlin Stackable; Megan Carney; Lauren Martin; Thomas Osterholt; Jeff L Staudinger
Journal:  Cells       Date:  2021-11-22       Impact factor: 6.600

9.  Alcohol-induced autophagy via upregulation of PIASy promotes HCV replication in human hepatoma cells.

Authors:  Meihua Ran; Hui Chen; Bingyu Liang; Weibo Liao; Junjun Jiang; Jiegang Huang; Chuanyi Ning; Ning Zang; Bo Zhou; Yanyan Liao; Huifang Liu; Fengxiang Qin; Quanlue Yang; Jieliang Li; Wenzhe Ho; Hao Liang; Li Ye
Journal:  Cell Death Dis       Date:  2018-09-05       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.